Effects of Tranilast on TGF- Β/smad Pathways in Rats with Chronic Cyclosporine A Nephrotoxicity

HU Lijuan,LI Shasha,TAO Ye,LIU Qifeng,ZHANG Chongjie,WU Xin,LI Dandan,LUO Zhijuan
2009-01-01
Abstract:Objective To investigate the effects of tranilast on TGF-β/Smad pathways in rats with chronic cyclosporine A nephrotoxicity. Methods Total of 34 SD rats were randomly divided into 6 groups:normal control group (N) received olive oil only by gavage; model control group (M) received CsA 20 mg/(kg·d) by gavage; Low (T1),median (T2) and high (T4)-dose group of tranilast treatment were given CsA 20 mg/(kg·d) and tranilast 100,200 and 400 mg/(kg·d) by gavage,respectively; Irbesartan treatment group (A) were given CsA 20 mg/(kg·d) and irbesartan 10 mg/(kg·d) by gavage. All rats were on low salt diet for 5 weeks,and kidneys were harvested at the end of the 4th week. TGF-β1,Smad3,and Smad7 were detected by semi-quantitative RT-PCR and immunohistochemistry.Results Morphologically,kidneys in group M exhibited significantly more fibrosis,which was blunted by tranilast. Either semi-quantitative RT-PCR or immunohistochemistry showed the expressions of TGF-β1 and Smad3 of the kidneys in group M were significantly higher than those in group N. Tranilast decreased the levels of TGF-β1 and Smad3,while increased the levels of Smad7 dose-dependently. High dose Tranilast displayed similar effects with irbesartan. Conclusion Tranilast shows a renal protective effect against chronic CsA nephrotoxicity in rat model by decreasing the levels of TGF-β1 and Smad3 and increasing the level of Smad7.
What problem does this paper attempt to address?